Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation

Abstract

Macrophage colony-stimulating factor (M-CSF or CSF-1) is known to have a broad range of actions on myeloid cells maturation, including the regulation of macrophage differentiation, proliferation and survival. Macrophages generated by M-CSF stimulus have been proposed to be alternatively activated or M2 phenotype. M-CSF is commonly overexpressed by tumors and is also known to enhance tumor growth and aggressiveness via stimulating pro-tumor activities of tumor-associated macrophages (TAMs). Currently, inhibition of CSF-1/CSF-1R interaction by therapeutic antibody to deplete TAMs and their pro-tumor functions is becoming a prevalent strategy in cancer therapy. However, its antitumor activity shows a limited single-agent effect. Therefore, macrophages in response to M-CSF interruption are pending for further investigation. To achieve this study, bone marrow derived macrophages were generated in vitro by M-CSF stimulation for 7 days and then continuously grown until day 21 in M-CSF absence. A selective pressure for cell survival was initiated after withdrawal of M-CSF. The surviving cells were more prone to M2-like phenotype, even after receiving interleukin-4 (IL-4) stimulation. The transcriptome analysis unveiled that endogenous CSF-1 level was dramatically up-regulated and numerous genes downstream to CSF-1 covering tumor necrosis factor (TNF), ras-related protein 1 (Rap1) and phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) signaling pathway were significantly modulated, especially for proliferation, migration and adhesion. Moreover, the phenomenal increase of miR-21-5p and genes related to pro-tumor activity were observed in parallel. In summary, withholding of CSF-1/CSF-1R interaction would rather augment than suspend the M-CSF-driven pro-tumor activities of M2 macrophages in a long run.

M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps

“…Therefore, whether M2 macrophages modulate the expression of NOX2 in an indirect way needs further investigation. CSF1R is the receptor of CSF1 (also known as M-CSF) which performs as an essential regulator of macrophage activation, polarization and proliferation ( 59 ). Macrophages undergoing M-CSF stimulation are activated to a phenotype that could regulate angiogenesis and tissue remodeling ( 60 ).…”

Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression

“…CSF-1R is thus a prime target for treating solid tumors such as prostate or breast cancer alone or in combination with chemotherapy [37] or radiation therapy [38]. Though targeting CSF-1R expression on TAM appears as a promising strategy [39], the beneficial effects still need to be further investigated [40][41][42]. Second, numerous studies have demonstrated that CSF-1R also drives tumor cell progression in several cancer types, including renal cell carcinoma [43], ovarian cancer [44], colorectal cancer [45], bladder cancer [46], mesothelioma [47], and melanoma [48].…”

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation

“…However, in the process of AS, due to sustaining inflammation response, macrophages are continuously recruited to lesion sites. Monocytes firstly differentiate to macrophages (M0) due to cytokines, such as M-CSF ( 17 ). Although the differentiation of monocytes to macrophages is unreversible, macrophages possess eminent plasticity, i.e., switching their phenotypes and functioning according to external signals ( 18 ).…”